Showing results (161-170 of 219) with videos related to

Sort By:
Pageof 22
Journal of Neurology, Neurosurgery, and Psychiatry|March 1, 2024
Does sex influence the natural history of idiopathic adult-onset dystonia?Vittorio Velucci, Sarah Idrissi, Roberta Pellicciari, et al.
Plos One|October 23, 2024
Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trialFrancesca Lea Saibene, Cristina Agliardi, Anna Salvatore, et al.
European Journal of Human Genetics : EJHG|April 14, 2005
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in ItaliansDaniele Ghezzi, Cecilia Marelli, Alessandro Achilli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 6, 2022
TWNK in Parkinson's Disease: A Movement Disorder and Mitochondrial Disease Center Perspective StudyMarco Percetti, Giulia Franco, Edoardo Monfrini, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 1, 2026
Multicenter validation of the Italian Pain in Dystonia Scale in idiopathic adult-onset cervical dystoniaAntonella Muroni, Vittorio Velucci, Davide Martino, et al.
Annals of Neurology|January 10, 2002
PARK6-linked parkinsonism occurs in several European familiesEnza Maria Valente, Francesco Brancati, Alessandro Ferraris, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 27, 2018
Mitochondrial dysfunction in fibroblasts of Multiple System AtrophyGiacomo Monzio Compagnoni, Giulio Kleiner, Andreina Bordoni, et al.
The Lancet. Neurology|March 18, 2024
Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trialAlberto J Espay, Fabrizio Stocchi, Rajesh Pahwa, et al.
Human Mutation|March 12, 2008
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrumRoberta Marongiu, Alessandro Ferraris, Tàmara Ialongo, et al.
Science (New York, N.Y.)|April 17, 2004
Hereditary early-onset Parkinson's disease caused by mutations in PINK1Enza Maria Valente, Patrick M Abou-Sleiman, Viviana Caputo, et al.
Pageof 22